Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 2012. Start Trial.
Date Value
October 12, 2026 8.54
October 09, 2026 8.77
October 08, 2026 8.13
October 07, 2026 8.625
October 06, 2026 8.39
October 05, 2026 8.94
October 02, 2026 8.72
October 01, 2026 8.84
September 30, 2026 9.30
September 29, 2026 9.72
September 28, 2026 9.81
September 25, 2026 9.755
September 24, 2026 10.06
September 23, 2026 9.66
September 22, 2026 10.05
September 21, 2026 9.38
September 18, 2026 9.16
September 17, 2026 9.875
September 16, 2026 10.12
September 15, 2026 10.25
September 14, 2026 11.04
September 11, 2026 11.30
September 10, 2026 10.88
September 09, 2026 10.57
September 08, 2026 10.96
Date Value
September 04, 2026 11.47
September 03, 2026 10.84
September 02, 2026 10.15
September 01, 2026 10.37
August 31, 2026 10.43
August 28, 2026 10.70
August 27, 2026 9.01
August 26, 2026 9.10
August 25, 2026 7.87
August 24, 2026 7.47
August 21, 2026 7.85
August 20, 2026 7.79
August 19, 2026 7.90
August 18, 2026 7.899
August 17, 2026 7.52
August 14, 2026 7.54
August 13, 2026 7.00
August 12, 2026 7.18
August 11, 2026 7.73
August 10, 2026 7.53
August 07, 2026 7.00
August 06, 2026 8.08
August 05, 2026 7.50
August 04, 2026 7.79
August 03, 2026 7.36

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
DBV Technologies SA 9.55
Cellectis SA 1.18
Bicycle Therapeutics Plc 3.80
argenx SE 812.30
Autolus Therapeutics Plc 1.74